The effect of -amino butyric acid (GABA) on neuronal firing rate in rat suprachiasmatic nucleus (SCN) slices was examined using continuous recording methods. GABA inhibited neuronal discharge during subjective day and subjective night in a concentration-dependent manner characterized by two apparent affinity states. The GABA A receptor agonist muscimol caused potent inhibition regardless of circadian time; repeated applications of the agonist did not reverse the direction of effect. The GABA A receptor antagonists bicuculline and picrotoxin increased excitability when applied either during subjective day or night. A significant increase in GABA A receptor-mediated inhibition, as well as endogenous GABA-ergic tone, was observed on the second day after slice preparation. The GABA B receptor agonist baclofen inhibited cell firing during subjective day and night, but the GABA B antagonist phaclofen had no significant effect.
Introduction
The neurons of the mammalian suprachiasmatic nucleus discharge in a circadian pattern linked to the light/dark cycle, entraining circadian behaviors and homeostatic mechanisms (Ralph et al. 1990; Rusak and Zucker 1979; van den Pol and Dudek 1993) .
The neurons of the SCN maintain a circadian discharge rhythm in vivo and in vitro in the absence of external entraining stimuli such as light (Bouskila and Dudek 1993; Gillette and Reppert 1987; Gribkoff et al. 1998; Miche and Colwell 2001) . Individual dissociated SCN neurons, and even immortalized SCN cell lines, also display intrinsic circadian rhythms (Earnest et al. 1999; Liu and Reppert 2000; Shirakawa et al. 2000; Welsh et al. 1995) . These data suggest that intrinsic neuronal properties are responsible for the ability to discharge rhythmically, and that synchronized rhythms are maintained for long periods in vitro. Recently several genetic components of the mammalian intrinsic clock mechanism were identified based on homology with clock genes in simpler systems (Bae et al. 2001; Chang and Reppert 2001; Dunlap 1999; Herzog et al.1998; Panda et al. 2002) .
Little is known, however, about the mechanisms whereby clock genes ultimately determine circadian rhythm-dependent changes in neuronal firing rates. Conceivably, these changes could result from changes in the expression of ion channels and transporters, or changes in the degree or nature of local circuit interactions, among many possibilities. The identification of contributors to circadian rhythm generation is a key question in circadian rhythm reasearch.
Neurotransmitters may shape the response of SCN neurons to timing cues, modulate intrinsic clock properties, alter neuronal synchrony, or even contribute to rhythm generation. The primary extrinsic regulator of the precise timing of these rhythms in vivo is the influence of the retino-hypothalamic tract transmitting visual information to the SCN, a pathway that releases glutamate, pituitary adenylate cyclase activating polypeptide and substance P as neurotransmitters or neuromodulators (Abe et al. 1996; De Vries et al. 1993; Hannibal et al. 2000; Kim et al. 1999) . In addition, several other intra-and extranuclear neurotransmitters and peptides can alter the timing of circadian discharge rhythms in the SCN. These include the pineal hormone melatonin, as well as serotonin and neuropeptide Y (Cassone 1998; Ehlen et al. 2001; Liu et al. 1997; Gribkoff et al. 1998) . The most abundant transmitter in the SCN, originating primarily within the component neurons of the SCN itself, is -aminobutyric acid (GABA) (Buijs et al. 1994; Castel and Moore 2000; Moore and Speh 1993; Moore et al. 2002; O'Hara et al. 1995; van den Pol 1986; van den Pol and Gorcs 1986) . The actions of GABA in the SCN have been previously investigated, yet there is considerable recent controversy concerning the degree and direction of its regulation of discharge patterns, and hence its role(s), in this important nucleus (De Jeu and Pennartz 2002; Gribkoff et al. 1997; Liu and Reppert 2000; Shimura et al. 2002; Shirakawa et al. 2000; Wagner et al. 1997; .
GABA, acting primarily through interaction with GABA A and GABA B receptors, produces neuronal inhibition in most brain regions through membrane hyperpolarization and increased membrane conductance, effectively shunting transmembrane voltage shifts.
However, under some circumstances, such as early in development, GABA can be depolarizing and potentially excitatory (Chen et al. 1996; Cherubini et al. 1991; Han et al. 2002; Obrietan and van den Pol 1995; Staley et al.1995) . In the SCN, most cells and a large proportion of synapses are immunopositive for the presence of GABA, and several GABA receptors and receptor subunits are expressed in the SCN (Castel and Morris 2000; Decavel and van den Pol 1990; Gao et al. 1995; Moore and Speh 1993; Naum et al. 2001; O'Hara et al. 1995; Okamura et al. 1989; van den Pol 1993; van den Pol and Gorcs 1986) , suggesting that GABA plays an important role in this nucleus.
Initial electrophysiological studies found intrinsic GABA or extrinsic GABA application to be predominately inhibitory (Bos and Mirmiran 1993; Burgoon and Boulant 1998; Mason, Biello and Harrington 1991; Shibata, Liou and Ueki 1983a; 1983b; Tominaga et al. 1994) . In a more recent study of SCN cells in culture, virtually every cell tested was inhibited by GABA or GABA agonists (Liu and Reppert 2000) , although this has not been universal (Shirakawa et al. 2000) . When the relationship of the effect of GABA and circadian cycle were directly explored using single cell recording techniques, GABA was found to be predominately inhibitory during both subjective day and night Liu and Reppert 2000; Mason 1986; Mason, Biello and Harington 1991) . There is evidence that the GABA system is influenced by circadian rhythms, although these appear to be changes in degree rather than direction (Aguilar-Roblero et al. 1993; Cardinali and Golombek 1998; Huhman et al. 1996; Naum, Fernanda Rubio and Golombek 2001; Trachsel, Dodt and Zieglgansberger 1996) . These studies suggested that circadian variations in the GABA system were due to changes in GABA level or receptor expression. Several recent studies, however, have suggested that the nature of GABA's actions in the SCN may be phase-dependent.
Specifically, GABA was reported to be inhibitory during subjective night, but excitatory during subjective day by one group (Wagner et al. 1997 ). This has been attributed to a possible diurnal increase in intracellular chloride (Cl - ) concentration resulting in a shift in the Cl -reversal potential (Shimura et al. 2002; Wagner et al. 1997; . This required a new appraisal of GABA's role in circadian regulation, since these data suggested that GABA released locally in the SCN contributes to the generation of circadian discharge rhythms, or at least significantly influences their phasic amplitudes by dampening activity during subjective night and increasing activity during subjective day. Initial attempts to replicate these findings failed to confirm a circadian difference in GABA's effects (Gribkoff et al., 1999) . Curiously, results of another recent study suggest an opposite circadian phase-dependence for GABA's effects (inhibitory during subjective day, excitatory during subjective night) (de Jeu and Pennartz 2002) . The results of the latter study strongly suggest a technical origin of these contradictory results.
The current study represents an entirely new set of experiments, in relation to a previous short collaborative report dealing with GABA in the SCN (Gribkoff et al. 1999) .
We have examined the effects of GABA, and agonists and antagonists of GABA receptors, to more fully characterize the pharmacology and phase-dependent actions of this important neurotransmitter on the cells of the SCN, and delineate possible contributions to circadian rhythmicity. Specifically, using multi-unit activity (MUA)
recording techniques, we determined the concentration-response relationships of GABAergic agents in the SCN during subjective day and night, examined the effects of repeated applications of GABA agonists, and studied the effects of GABA receptor ligands on the timing and amplitude of circadian discharge rhythms in the SCN of the rat in vitro.
The techniques used in these experiments, while not designed to ascertain response profiles of individual SCN neurons, have at least 2 distinct advantages over both episodic single-unit and whole-cell patch recordings. MUA recording is the only technique that involves recording from the same groups of cells over complete circadian cycles in the relatively intact slice system, and demonstrates directly the response of cells during different components of the circadian rhythm (Bouskila and Dudek 1993; Gribkoff et al. 1998 ). In addition, it is relatively non-invasive and removes any opportunity for unintentional experimenter bias in cell sampling following initial electrode placement; the electrode is placed in the SCN and recording optimized, and then is untouched for the remainder of the experiment (as long as 72 h).
We found that GABA and GABA receptor agonists were inhibitory regardless of phase, and GABA A antagonists were excitatory regardless of phase. We also found that GABA-mediated inhibition of spontaneous activity in SCN slice preparations increased after long periods of incubation in vitro. Finally, we altered the ionic composition of the bathing medium to match the extracellular concentration of potassium (K + ) in previous studies (Wagner et al. 1997; to determine the role of this component of the ionic milieu on the regulation of GABA's effects in the nucleus. We found that it had small but phase-independent effects on the response to GABA receptor activation.
Our data demonstrate that the predominant role for GABA in the SCN is inhibition throughout the circadian cycle, and that this inhibitory influence increases with incubation in vitro.
Materials and Methods

Slice Preparation
Male 
Continuous MUA recording
To record multi-unit SCN electrical activity, a 76 µm-diameter, teflon-coated platinum-iridium wire electrode was lowered under visual inspection into the SCN using Slices were not used if their viability was compromised at any point in the experiment. Viability was confirmed by the presence of a clear circadian discharge rhythm over at least 2 days with a peak discharge rate on day 2 at least 60% of that recorded on day 1. The results of the present experiments (see results below) suggest that reductions in peak discharge rate on day 2 may not reflect viability as much as an increase in the level of endogenous GABA-mediated inhibition. Nevertheless, all slices used in these experiments involved these criteria to allow for direct comparison, particularly the presence of a circadian discharge rhythm for at least 2 days.
In some experiments the peak of the neuronal activity rhythm on day 2 was determined by fitting several hours of the data on either side of CT 6 in the subjective day as described previously (Gribkoff et al. 1998 ) using Kaleidagraph software (Synergy Software, Reading PA). Although this was not the primary focus of these experiments, the fitted activity peak was used to determine if the neuronal activity rhythm during subjective day 2 was phase-shifted by prior drug treatment.
Drugs
All drugs used in these experiments were purchased from Sigma (St. Louis, MO).
GABA, the GABA A receptor antagonist (-)-bicuculline methiodide, the GABA A receptor agonist muscimol HBr and the GABA B receptor antagonist phaclofen were dissolved directly in ACSF. Picrotoxin was prepared as a 100 mM stock solution in EtOH; the final experimental vehicle concentration was 0.1% EtOH. The GABA B receptor agonist (+)baclofen HCl was prepared as a 5 mM stock solution in DI water. The final vehicle concentrations were either 0.2% DI H 2 O or 0.8% DI H 2 O depending on the experimental concentration of baclofen. Effects of drug solutions were generally expressed as percent of vehicle control response, as defined above. Where concentration-response relationships were generated, EC 50 values were estimated using logistic fits of resulting curves using KaleidoGraph software (Synergy Software, Reading, PA).
Results
Inhibitory Effects of GABA in the SCN
GABA application at any of the tested time points in the diurnal discharge cycle produced a concentration-dependent decrease in neuronal firing rates (Fig. 1A ,B). While no detailed attempt was made to determine the degree to which longer GABA applications could result in tachyphylaxis, it was observed that inhibitory responses could be maintained for periods in excess of 1 hr during continuous GABA application without decrement. GABA-mediated inhibition was reversible even following prolonged administration. Given the much higher average discharge rates observed during subjective day, when inhibition was expressed as percent of control discharge rate the net effect was larger in subjective night (Fig. 1B) . The concentration-response curves for GABA applied during subjective day and night were best fit using a 2-site model, although the apparent contribution of the higher affinity site to the concentration-response to GABA was reduced during subjective day. The estimated EC 50 's for GABA effects during subjective day were 44.4 µM for the higher affinity site, and 1.31 mM for the lower affinity site. The EC 50 values for GABA effects during subjective night were 54.0 µM for the higher affinity site, and 2.31 mM for the low affinity site. Although these values were obtained in the absence of pharmacological manipulation of GABA reuptake, they suggested that at least two GABA receptor subtypes were present and functional in the SCN, and contributed to these responses. In these experimental conditions (ionic composition as described in methods for 'normal' incubation medium), the only multiunit response to GABA application was inhibition. Repeated application of GABA at a concentration near the apparent EC 50 within a subjective day resulted in inhibition that was similar in amplitude from application to application (Fig. 2) .
GABA receptor pharmacology Agonists
To determine the degree to which different GABA receptors contributed to the inhibitory effects of GABA application, specific agonists for GABA A and GABA B receptors, muscimol and baclofen, respectively, were applied at a range of concentrations during subjective day and night. Muscimol application during subjective day or night produced potent and profound inhibition (Figs. 3A,3B ). There was no significant difference in EC 50 estimates (1.4 µM subjective day; 0.76 µM subjective night) between curves generated during subjective day and subjective night. The GABA B agonist baclofen, however, while equally effective when applied during either subjective day or subjective night ( Fig.4A, 4B ), had significantly greater potency when applied during subjective night (EC 50 5.2 µM subjective day; 36 nM subjective night).
Antagonists
Application of the GABA A receptor antagonist bicuculline (Fig. 5A ) or picrotoxin ( Fig. 5B ) always produced increases in neuronal activity when applied to SCN slices at mid-subjective night or mid-subjective day. In some cases, in the presence of the antagonist, the level of discharge during subjective night was almost as great as the peak of the spontaneous activity observed in the previous subjective day. However, application of the antagonist at or near the peak on the following subjective day produced a similar level of increase in the discharge rate (Fig. 5 ). This suggests that the level of GABA-mediated inhibition, while clearly important in determining the maximum discharge rates at any particular time point in the rhythm, had only a relatively small contribution to the generation of the rhythm per se. Long-term application of either antagonist did not remove circadian rhythmicity. The GABA B receptor antagonist phaclofen had no significant effect on basal firing rates at any time point.
Evidence for a time-dependent increase in GABA transmission in SCN in vitro
As discussed above, repeated application of either GABA or the GABA A agonist muscimol resulted in consistent inhibition of neuronal firing, as did prolonged application of either compound. However, it was noted during the course of these experiments that the day of application greatly affected the degree of inhibition produced by GABA. In most experiments, experimental compounds were applied either during the subjective night after the day of slice preparation (day 1), or on the following subjective day (day 2).
However, in a separate group of experiments, the effect of application during subjective days 1 and 2 were compared, and it was found that responses to GABA agonists were greater during subjective day 2, when compared to responses generated on the day of slice preparation. There were very large increases in the responses to both GABA (see Fig. 2) and muscimol (Fig. 6A ) during successive subjective days, although the only response to either compound on either day was inhibition.
In many SCN slices, peak spontaneous neuronal activity levels were greater on the day of slice preparation than on subsequent days. We assumed that this reflected a decline in slice viability. However, an alternative explanation could be that lower control firing rates on day 2 reflect higher levels of endogenous tonic GABA neurotransmission, rather than decreased viability. To test this hypothesis, tonic inhibition was removed by a brief (1-2 hr) application of 25 µM BIC near CT 6 on day 1 and 2. The response to BIC application on both days was excitation. The absolute peak firing levels reached on both days was very similar in the presence of the antagonist, regardless of the amplitude of the pre-treatment discharge level (Fig. 6B) , suggesting that while more quiescent on day 2, the neurons were fully capable of firing at a rate comparable to that seen during the previous peak when tonic inhibition was removed. This strongly suggests that at least over this 2-day period neuronal firing rates are increasingly affected by a higher level of tonic GABA-ergic inhibition. The data for day-dependent inhibition and excitation for muscimol and BIC, respectively, are summarized in Fig. 6C . A modest (r=0.81) but significant linear correlation was fitted between the ratio of day 1 to day 2 spontaneous firing rate and the ratio of the effect of BIC on day 2 vs. day 1 (Fig. 6D) .
Phase modulation by GABA receptor antagonists
While phase-modulation by GABA receptor ligands was not a focus of this study, the effects of some of the pharmacological manipulations in this study on phase timing were evaluated. The time of drug application was CT 18-19 for antagonists and CT 5.5-6.5 for agonists, and the time of peak discharge rate on day 2 was recorded. The results are summarized in Fig. 7 . Significant phase shifts were only observed when either a combination of GABA antagonists or picrotoxin was applied at CT 18-19 on the subjective night after slice preparation. These data confirm that endogenous GABA has an influence on the timing of rhythms.
Effects of altering the concentration of extracellular K + on GABA inhibition
We performed experiments to determine if changes in ionic conditions could affect the direction of GABA-mediated discharge modulation. In particular, the extracellular concentration of K + used by Wagner and colleagues (1997; was 6.2 mM compared to our usual K + concentration of 5.4 mM. In this modified medium, the predominate effect of GABA application in our preparations was inhibition during subjective day and night. However, in 3 slices, a transient excitation was observed early in the period of GABA application, followed by inhibition (Fig. 8) . In 2 of these slices, wherein excitation was followed by inhibition during subjective night, the inhibition was followed by rebound excitation after cessation of drug application. While interesting, this transient excitation was observed when GABA was applied during subjective day or night, and was not limited to applications during subjective day.
Discussion and Conclusions
These results confirm that GABA is an important regulator of SCN function, and demonstrate that SCN neurons display significant temporal plasticity in terms of GABAergic tone and responsivity under these experimental conditions. We obtained no evidence from these studies to support the hypothesis of Wagner and colleagues (1997; ) and others (de Jeu and Pennartz 2002; Shimura et al. 2002 ) that GABA has differential actions during subjective day and night.
All of these studies, ours included, used in vitro preparations, either slices or dissociated neurons, all of which have caveats associated with the applicability of their results to the physiology of the SCN in vivo. In the present experiments we used MUA recording in SCN slices. This technique is relatively non-invasive, has no effect on intracellular ionic regulation per se, and is uniquely capable of recording neuronal activity continuously for several days over successive circadian rhythms in the slice preparation (Bouskila and Dudek 1993; Gribkoff et al. 1998; Gribkoff et al. 1999 ). This technique allowed us to measure the effects of GABA and GABA-receptor subtype-specific ligands on the same populations of SCN neurons over successive phases of the circadian cycle. In all cases, regardless of the time of drug application, GABA, the GABA A agonist muscimol, and the GABA B agonist baclofen produced concentration-dependent inhibition of the discharge of groups of SCN neurons. At maximally-effective concentrations of each agonist, the degree of inhibition was profound. These data indicate that effects of exogenous GABA were mediated by more than one receptor, likely a combination of GABA A and GABA B receptors, given the response profiles of the specific receptor agonists. No attempt was made to further pharmacologically characterize the subtype composition of SCN GABA A receptors. The only potentially significant day-night difference in GABA-ergic pharmacology observed in the study was an increase in baclofen potency during subjective night. The reasons for this are unknown.
These data, due to the use of MUA recording techniques, cannot exclude the possibility that some cells were excited by GABA. Only some form of single-cell recording, usually an episodic technique not capable of monitoring the activity of neurons for the entire circadian cycle, could directly address the question of whether some cells during subjective day or night are excited by GABA. Some previous single-cell studies have examined this using episodic recording. While the proportion of cells inhibited by GABA and GABA agonists varied from study to study, the majority were inhibited regardless of phase, and where examined the proportions were similar during subjective day and night Mason 1986; Mason, Biello and Harrington 1991) .
A single-cell recording technique that is non-episodic is the mutli-electrode array longterm recording of cultured SCN neurons (Liu and Reppert 2000; Shirakawa et al. 2000; Welsh et al. 1995) . Using this technique, all cells were inhibited by GABA and muscimol regardless of circadian time in one study (Liu and Reppert 2000) , while in another the majority of cells were excited by bicuculline, indicating that endogenous GABA was inhibitory (Shirakawa et al. 2000) . A distribution of GABA sensitivity was also seen in the study by Wagner and colleagues (1997) . However, in their study a small majority of cells sampled individually were inhibited during subjective night (56%) while a large majority were excited during subjective day (71%) by GABA. In our study the mean effect of GABA and GABA receptor subtype-specific agonist application was always inhibition, and the profound degree of maximal inhibition for GABA (Fig.1) , muscimol ( Fig.3) and baclofen (Fig.4) left little room for a significant proportion of cells to have been excited at any time point. Nevertheless, some cells may may have been excited by GABA at either time point. In our experiments inhibition continued for the duration of the longest applications of all of the agonists (>1 hr at highest tested concentrations) and was reversible. The only exception we noted was when extracellular K + was increased modestly to match that used by Wagner et al. (1997 Wagner et al. ( , 2001 ). The transient excitations seen in a small proportion of slices occurred during subjective night or subjective day. While we cannot rule out that GABA may have a differential effect in a subset of cells that were not adequately sampled by our extracellular recording techniques, we find this unlikely.
The data presented represent group means of recordings of groups of cells, and as such present the response of large numbers of SCN neurons. The neurons discharged in a predictable circadian pattern and remained viable throughout the course of the experiments.
GABA A receptor antagonism by BIC or picrotoxin resulted in excitation during subjective day or night, supporting the conclusion that endogenous GABA is likewise inhibitory. GABA therefore has a significant inhibitory influence in the nucleus under these recording conditions throughout the circadian cycle. We found no evidence to support the hypothesis that endogenous GABA, by inhibiting at night and exciting during the day, magnified the day-night differences in spontaneous activity which result in circadian rhythms in the SCN. In 2 slices, prolonged application of BIC from CT18 during subjective night to CT6 during subjective day resulted in an overall increase in neuronal excitability, but the shape of the rhythm remained relatively unchanged. The modest phase advance seen with antagonist combinations or with picrotoxin applied during subjective night extend previous findings that endogenous GABA can affect timing of rhythms and their response to timing cues (Mintz et al. 2002; Ralph and Menaker 1985; 1989; Rangarajan, Heller and Miller 1994) . The reasons for the greater effect of picrotoxin relative to BIC in these experiments is not understood. It is also unclear why muscimol did not have a significant effect on phase timing, as previously reported (Tominaga et al. 1994 ). In our experiments muscimol was applied at or near the peak of the discharge rhythm on day 1 (CT 5.5-6.5). A larger phase advance may have been observed if the agonist was applied earlier in the subjective day (Tominaga et al. 1994; Liu and Reppert 2000) . Note however, that muscimol and GABA have also been
shown to induce phase delays in individual clock cells according to a phase schedule consistent with the advances we and others have observed in response to GABA receptor antagonism or GABA Cl -channel block by picrotoxin (Liu and Reppert 2000) . The magnitude of the delay induced by GABA and mucimol during late subjective day/early subjective night was much greater than advances seen with agonist application during early subjective day. Taken together, these data confirm a complex role for GABA in the regulation of circadian phase.
We observed no significant effect of the GABA B receptor antagonist phaclofen in the SCN when applied during subjective day or night. We did not investigate this as extensively as we did GABA A antagonism, and cannot entirely exclude some participation of these receptors in mediating the effects of endogenous GABA. However, although exogenously-applied baclofen can profoundly inhibit SCN cells, and the responses to exogenously applied GABA appear to be comprised of multi-receptor components, endogenous GABA exerts its effects predominately via interaction with GABA A or other phaclofen-insensitive receptors.
The finding that endogenous GABA inhibition during subjective day was increased as a function of incubation time after slice preparation was both novel and unexpected. While cells appeared to be viable under these conditions for the entire recording period (as indicated by their maximal firing rates in the presence of bicuculline), their spontaneous discharge rates during subjective day appeared to be greatly affected by increasing levels of tonic inhibition. The finding that the effects of both exogenously applied GABA A agonists (including muscimol) and the antagonist bicuculline are significantly increased on the second day in vitro strongly suggests an increase in tonic inhibition resulting (at least) from an increase in receptor density.
Whether there is a concomitant increase in tonic endogenous GABA release cannot be determined from these experiments. In addition, we did not examine whether GABA B receptor-mediated responses are likewise affected by time of incubation. We do not yet know whether this increase in inhibitory tone affects other pharmacological responses at any time point during prolonged experiments, but these data do suggest that care must be exercised to take into account changing levels of inhibition on such factors as rhythm shifts and the amplitudes of direct pharmacological responses in vitro. One advantage of the multi-unit recording method is the ability to detect phenomena such as the one described here. With episodic recording techniques peak aggregate firing rates cannot be easily compared between comparable points in successive rhythms.
In conclusion, our data continue to strongly support the hypothesis that GABA is an inhibitory neurotransmitter in the mature rat SCN throughout the circadian cycle in vitro. Employing long-term and relatively non-invasive recording techniques we never observed a circadian rhythm-dependent change in the direction of the effects of GABA receptor ligands. We do not understand the reasons for circadian time-dependent reversals of the direction of GABA-ergic influence observed first by Wagner and colleagues (1997) , and later observed in the opposite direction by de Jeu and Pennartz (2001) A.) The two panels display examples of GABA-mediated inhibition of neuronal firing in SCN slices maintained over multiple 24-h cycles. GABA-mediated inhibition was observed during both subjective day (CT 0-12) and subjective night .
Under these conditions the response to GABA application was always inhibition.
B.) Concentration-response curves for GABA-mediated inhibition in groups of SCN slices (n 6 for each concentration, total slices =72; n=6 slices for vehicle control), expressed as percent inhibition of neuronal firing relative to the effect of vehicle. Repeated application of GABA (5 mM) produced consistent inhibition of neuronal discharge during subjective day. In slices exhibiting even modestly decreased peak firing rates on day 2, such as was seen with this slice, the response to GABA was significantly enhanced during the second diurnal phase (see text and Figure 6 ). A.) Examples of responses to the GABA A -receptor agonist muscimol (0.01-100 µM)
during subjective day and night. Neuronal responses were potently inhibited by muscimol regardless of the subjective circadian phase. Note the nearly total degree of maximal inhibition in these groups of neurons, suggesting that no significant
proportion of recorded cells could be excited during either subjective day or night.
B.) Concentration-response relationships for muscimol inhibition of neuronal discharge.
The agonist was more effective during subjective day, while potency was not significantly different. Muscimol was applied at or near CT 18 during subjective night and at or near CT 6 during subjective day; n 6 for each concentration at each time point (n=81 slices total vs. 26 vehicle control slices). The GABA A receptor antagonists bicuculline (25 µM; A.) and picrotoxin (25 µM; B.) produced neuronal excitation when applied to SCN slices near CT 18 during subjective night or near CT 6 during subjective day. Excitation in response to these drugs was maximal at the concentrations shown, and in no case was inhibition observed in response to GABA A receptor antagonism at either time point (n = 6 for bicuculline vs. 6 vehicle control slices, n = 7 for picrotoxin vs. 7 vehicle control slices).
Figure 6.
Some decrement in peak neuronal discharge levels was observed in most slices from subjective day 1 (the day of slice preparation) to subjective day 2. It was also noted that responses to GABA A receptor agonists and antagonists were significantly greater in those slices wherein a decrement was observed. In the examples shown the agonist muscimol (A.) and the antagonist bicuculline (B.) produced much greater inhibition and excitation, respectively, when applied near the peak of neuronal firing on day 2, when compared with day 1. Note that the level of neuronal activity depicted in the presence of bicuculline on day 2 in B. is nearly equal to that observed on day 1 in the presence of the antagonist, despite starting from a lower baseline. This is quantified in C., where the difference in responses to antagonist (n = 9) and agonist (n = 10) were significantly greater on day 2 (p<0.05). D. Correlation between the ratios of the effects of the antagonist bicuculline on day 2 vs. day 1, and the peak spontaneous firing rates on day 1 vs day 2 prior to the addition of the antagonist. Application of GABA antagonists (CT 17.5-18.5) had modest effects on circadian phase timing. Significant phase shifts, relative to control slices (n 6 control slices for each group), were observed in response to a combination of antagonists (bicuculline, picrotoxin and phaclofen; 25 µM all; n = 10 slices vs. 5 vehicle control slices) and to picrotoxin alone (n= 8 slices vs. 5 vehicle control slices). BIC alone (n=5 slices vs. 5 vehicle control slices) and phaclofen alone (n=5 slices vs. 5 vehicle control slices) produced no significant shift in phase. Application of the GABA A agonist muscimol (n=5 slices vs. 5 vehicle control slices) or the GABA B agonist baclofen (n=5 vs. 5 vehicle control slices) at CT 5.5-6.5 likewise produced no significant shift in phase. Circadian Time (Hr) 2.5 µM muscimol CT17.5-18.5
